RxDoctor Payments Data

David Kim, MD

Pain Medicine · Detroit, MINPI 1609940113

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations.

$7,787in general payments, 2019–2025

Across 87 payments — averaging $89.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Medtronic$1K
  • Boston Scientific$1K
  • Nevro Corp.$1K
  • Avanos Medical$424
  • Globus Medical$383
  • plus $2K from 12 others
$11,675in research payments, 2019–2025

Across 7 payments — averaging $1667.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Nevro Corp.$12K

What the payments were for

  • Food & beverage$7,763100%
  • Education$240%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,787 in reported general payments places this provider in the 80th percentile of 139 pain medicine providers in Michigan.

See all pain medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$81,591
Medicare patients
295
Services billed
854

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin47$1,165
Gabapentin67$1,098
Tizanidine Hcl31$1,044
Diclofenac Potassium21$706
Diclofenac Sodium14$589
Celecoxib37$545
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen27$377
Lidocaine-PrilocaineLidocaine/Prilocaine30$291
Morphine Sulfate ErMorphine Sulfate12$249
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$245
Methocarbamol11$156

Paid to pharmacies, not to this prescriber.

Other pain medicine in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →